
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.680 | 7.680 | 0.000 |
Stocks | 92.320 | 92.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.918 | 18.283 |
Price to Book | 3.234 | 3.061 |
Price to Sales | 2.922 | 2.247 |
Price to Cash Flow | 13.148 | 12.317 |
Dividend Yield | 1.884 | 2.027 |
5 Years Earnings Growth | 9.080 | 10.580 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 19.500 | 16.698 |
Industrials | 18.150 | 11.552 |
Healthcare | 17.070 | 13.053 |
Technology | 15.680 | 23.815 |
Consumer Defensive | 8.250 | 7.490 |
Consumer Cyclical | 7.810 | 10.673 |
Basic Materials | 6.870 | 3.954 |
Communication Services | 5.630 | 7.933 |
Real Estate | 1.040 | 2.747 |
Number of long holdings: 90
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Visa A | US92826C8394 | 3.24 | 335.11 | -0.21% | |
The Charles Schwab | US8085131055 | 2.41 | 76.00 | -1.54% | |
Microsoft | US5949181045 | 2.39 | 376.63 | -2.36% | |
Willis Towers Watson | IE00BDB6Q211 | 2.30 | 327.87 | +0.22% | |
Medtronic | IE00BTN1Y115 | 2.24 | 83.49 | +1.35% | |
Schneider Electric | FR0000121972 | 2.22 | 205.85 | -1.37% | |
Becton Dickinson | US0758871091 | 1.99 | 202.75 | +0.35% | |
Alphabet A | US02079K3059 | 1.99 | 154.71 | -1.02% | |
Roche Holding Participation | CH0012032048 | 1.90 | 254.40 | -0.39% | |
Thermo Fisher Scientific | US8835561023 | 1.88 | 441.21 | +0.05% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS Investment Funds Global GBP | 407.05M | 7.14 | 2.27 | 9.82 | ||
MFS Global Concentrated Equity Fucg | 115.78M | -0.82 | 3.71 | 9.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review